CompletedPhase 1NCT05220605

Nebulised BromAc in Healthy Volunteers

Studying Adult acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mucpharm Pty Ltd
Principal Investigator
Frank van Haren, MD, PhD
St George Hospital, Director of Intensive Care
Intervention
BromAc(drug)
Enrollment
12 enrolled
Eligibility
18-70 years · All sexes
Timeline
20222022

Study locations (1)

Collaborators

St George Hospital, Australia · Mobius Medical Pty Ltd.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05220605 on ClinicalTrials.gov

Other trials for Adult acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Adult acute respiratory distress syndrome

← Back to all trials